69 related articles for article (PubMed ID: 20079769)
1. Isolation and identification of arabinose mycolates of Cell Wall Skeleton (CWS) derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105).
Uenishi Y; Kusunose N; Yano I; Sunagawa M
J Microbiol Methods; 2010 Mar; 80(3):302-5. PubMed ID: 20079769
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of mycolic acid subclass and molecular species composition of Mycobacterium bovis BCG Tokyo 172 cell wall skeleton (SMP-105).
Uenishi Y; Fujita Y; Kusunose N; Yano I; Sunagawa M
J Microbiol Methods; 2008 Feb; 72(2):149-56. PubMed ID: 18178279
[TBL] [Abstract][Full Text] [Related]
3. Separation and molecular characterization of mycolic acid from the cell wall skeleton of Mycobacterium bovis BCG Tokyo 172 (SMP-105) and BCG substrains by normal-phase high performance liquid chromatography and liquid chromatography/mass spectrometry.
Uenishi Y; Takii T; Yano I; Sunagawa M
J Microbiol Methods; 2009 Jun; 77(3):320-2. PubMed ID: 19328829
[TBL] [Abstract][Full Text] [Related]
4. Morphological study on Mycobacterium bovis BCG Tokyo 172 cell wall skeleton (SMP-105).
Uenishi Y; Kawabe K; Nomura T; Nakai M; Sunagawa M
J Microbiol Methods; 2009 May; 77(2):139-44. PubMed ID: 19318051
[TBL] [Abstract][Full Text] [Related]
5. Optimization of cell-wall skeleton derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105) emulsion in delayed-type hypersensitivity and antitumor models.
Miyauchi M; Murata M; Fukushima A; Sato T; Nakagawa M; Fujii T; Koseki N; Chiba N; Kashiwazaki Y
Drug Discov Ther; 2012 Aug; 6(4):218-25. PubMed ID: 23006993
[TBL] [Abstract][Full Text] [Related]
6. Study on the cell wall skeleton derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105): establishment of preparation and analytical methods.
Uenishi Y; Okada T; Okabe S; Sunagawa M
Chem Pharm Bull (Tokyo); 2007 Jun; 55(6):843-52. PubMed ID: 17541180
[TBL] [Abstract][Full Text] [Related]
7. Activation of Toll-like receptor 2 by a novel preparation of cell wall skeleton from Mycobacterium bovis BCG Tokyo (SMP-105) sufficiently enhances immune responses against tumors.
Murata M
Cancer Sci; 2008 Jul; 99(7):1435-40. PubMed ID: 18452561
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant activity of mycobacterial fractions. I. Purification and in vivo adjuvant activity of cell wall skeletons of Mycobacterium bovis BCG, Nocardia asteroides 131 and Corynebacterium diphtheriae PW8.
Azuma I; Kanetsuna F; Taniyama T; Yamamura Y; Hori M
Biken J; 1975 Mar; 18(1):1-13. PubMed ID: 807194
[TBL] [Abstract][Full Text] [Related]
9. Arabino-mycolates derived from cell-wall skeleton of Mycobacterium bovis BCG as a prominent structure for recognition by host immunity.
Miyauchi M; Murata M; Shibuya K; Koga-Yamakawa E; Uenishi Y; Kusunose N; Sunagawa M; Yano I; Kashiwazaki Y
Drug Discov Ther; 2011 Jun; 5(3):130-5. PubMed ID: 22466242
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and TNF-alpha inducing activities of mycoloyl-arabinan motif of mycobacterial cell wall components.
Ishiwata A; Akao H; Ito Y; Sunagawa M; Kusunose N; Kashiwazaki Y
Bioorg Med Chem; 2006 May; 14(9):3049-61. PubMed ID: 16426852
[TBL] [Abstract][Full Text] [Related]
11. Gene-inducing program of human dendritic cells in response to BCG cell-wall skeleton (CWS), which reflects adjuvancy required for tumor immunotherapy.
Ishii K; Kurita-Taniguchi M; Aoki M; Kimura T; Kashiwazaki Y; Matsumoto M; Seya T
Immunol Lett; 2005 May; 98(2):280-90. PubMed ID: 15860229
[TBL] [Abstract][Full Text] [Related]
12. Modified multiplex PCR for identification of Bacillus Calmette-Guérin substrain Tokyo among clinical isolates.
Seki M; Sato A; Honda I; Yamazaki T; Yano I; Koyama A; Toida I
Vaccine; 2005 May; 23(24):3099-102. PubMed ID: 15837207
[TBL] [Abstract][Full Text] [Related]
13. Biologically active components from mycobacterial cell walls. III. Production of experimental allergic encephalomyelitis in guinea-pigs.
Meyer TJ; Azuma I; Ribi EE
Immunology; 1975 Feb; 28(2):219-29. PubMed ID: 804436
[TBL] [Abstract][Full Text] [Related]
14. Mycolic acid patterns of representatives of Mycobacterium bovis BCG.
Minnikin DE; Parlett JH; Magnusson M; Ridell M; Lind A
J Gen Microbiol; 1984 Oct; 130(10):2733-6. PubMed ID: 6392477
[TBL] [Abstract][Full Text] [Related]
15. Application of BCG-CWS as a Systemic Adjuvant by Using Nanoparticulation Technology.
Masuda H; Nakamura T; Noma Y; Harashima H
Mol Pharm; 2018 Dec; 15(12):5762-5771. PubMed ID: 30380885
[TBL] [Abstract][Full Text] [Related]
16. Isolation and analysis of Mycobacterium tuberculosis mycolic acids.
Vilchèze C; Jacobs WR
Curr Protoc Microbiol; 2007 Jun; Chapter 10():Unit 10A.3. PubMed ID: 18770604
[TBL] [Abstract][Full Text] [Related]
17. [Thin-layer chromatography of mycolic acids methanolysates of whole-cell in Mycobacterium and related bacteria].
Zhuang YH; Zhang Y; Han YH; Liu ZH; Ruan JS
Wei Sheng Wu Xue Bao; 1989 Feb; 29(1):15-9. PubMed ID: 2800535
[TBL] [Abstract][Full Text] [Related]
18. Two receptor theory in innate immune activation: studies on the receptors for bacillus Culmet Guillen-cell wall skeleton.
Seya T; Matsumoto M; Tsuji S; Begum NA; Nomura M; Azuma I; Hayashi A; Toyoshima K
Arch Immunol Ther Exp (Warsz); 2001; 49 Suppl 1():S13-21. PubMed ID: 11603865
[TBL] [Abstract][Full Text] [Related]
19. Chemical structure of the cell wall of Mycobacterium tuberculosis var. bovis, strain BCG.
Petit JF; Wietzerbin J; Das BC; Lederer E
Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):118-25. PubMed ID: 126548
[TBL] [Abstract][Full Text] [Related]
20. Inflammation induced by mycolic acid-containing glycolipids of Mycobacterium bovis (BCG).
Silva CL
Braz J Med Biol Res; 1985; 18(3):327-35. PubMed ID: 3915215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
